Literature DB >> 28477079

[Irreversible electroporation (IRE) : A minimally invasive therapeutic option in prostate cancer].

P Wiggermann1, K Brünn2, W Bäumler2.   

Abstract

CLINICAL PROBLEM: Prostate cancer is one of the most common malignant diseases in older men. As such, screening and early detection are of crucial importance. STANDARD TREATMENT: The standard management of prostate cancer includes radical prostatectomy, radiation therapy, or hormonal therapy. These standard therapies yield excellent oncologic results, but also produce significant side effects. In cases of low-risk prostate cancer, these therapies might result in over-treatment; for this reason, active surveillance has been introduced. However, acceptance of this strategy varies between patients. TREATMENT INNOVATIONS: Irreversible electroporation is a novel non-thermal ablation technique for soft tissues. The ablation mechanism of irreversible electroporation has some theoretical advantages in the treatment of prostate cancer. It allows image-guided focal treatment of malignant prostate tissue and a potential sparing of adjacent structures, thereby theoretically resulting in a marked reduction in treatment-related side effects compared with standard management. PRACTICAL RECOMMENDATIONS: Although irreversible electroporation is a promising ablation technique, it should only be used in the context of clinical trials to treat prostate cancer due to the current lack of solid evidence for this new technology.

Entities:  

Keywords:  Ablation; Active surveillance; Image-guided; Radiology; Side-effects profile

Mesh:

Year:  2017        PMID: 28477079     DOI: 10.1007/s00117-017-0251-x

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  20 in total

Review 1.  Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy.

Authors:  Vincenzo Ficarra; Giacomo Novara; Thomas E Ahlering; Anthony Costello; James A Eastham; Markus Graefen; Giorgio Guazzoni; Mani Menon; Alexandre Mottrie; Vipul R Patel; Henk Van der Poel; Raymond C Rosen; Ashutosh K Tewari; Timothy G Wilson; Filiberto Zattoni; Francesco Montorsi
Journal:  Eur Urol       Date:  2012-06-01       Impact factor: 20.096

2.  Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy.

Authors:  D C Chang; T S Reese
Journal:  Biophys J       Date:  1990-07       Impact factor: 4.033

Review 3.  Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy.

Authors:  Vincenzo Ficarra; Giacomo Novara; Raymond C Rosen; Walter Artibani; Peter R Carroll; Anthony Costello; Mani Menon; Francesco Montorsi; Vipul R Patel; Jens-Uwe Stolzenburg; Henk Van der Poel; Timothy G Wilson; Filiberto Zattoni; Alexandre Mottrie
Journal:  Eur Urol       Date:  2012-06-01       Impact factor: 20.096

4.  Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings during follow up.

Authors:  L P Beyer; B Pregler; C Nießen; K Michalik; M Haimerl; C Stroszczynski; E M Jung; P Wiggermann
Journal:  Clin Hemorheol Microcirc       Date:  2016       Impact factor: 2.375

5.  [Prostate cancer].

Authors:  T Franiel; N Eckardt; M Waginger; M Horstmann
Journal:  Radiologe       Date:  2014-05       Impact factor: 0.635

Review 6.  Imaging of recurrent prostate cancer.

Authors:  Jurgen J Fütterer
Journal:  Radiol Clin North Am       Date:  2012-10-11       Impact factor: 2.303

7.  Irreversible Electroporation for Surgical Renal Masses in Solitary Kidneys: Short-Term Interventional and Functional Outcome.

Authors:  Steffen J Diehl; Nils Rathmann; Michael Kostrzewa; Manuel Ritter; Arman Smakic; Stefan O Schoenberg; Maximilian C Kriegmair
Journal:  J Vasc Interv Radiol       Date:  2016-06-09       Impact factor: 3.464

8.  Long-term functional outcomes after treatment for localized prostate cancer.

Authors:  Matthew J Resnick; Tatsuki Koyama; Kang-Hsien Fan; Peter C Albertsen; Michael Goodman; Ann S Hamilton; Richard M Hoffman; Arnold L Potosky; Janet L Stanford; Antoinette M Stroup; R Lawrence Van Horn; David F Penson
Journal:  N Engl J Med       Date:  2013-01-31       Impact factor: 91.245

9.  Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control.

Authors:  F Ting; M Tran; M Böhm; A Siriwardana; P J Van Leeuwen; A M Haynes; W Delprado; R Shnier; P D Stricker
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-10-13       Impact factor: 5.554

10.  The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol.

Authors:  Peter G K Wagstaff; Daniel M de Bruin; Patricia J Zondervan; C Dilara Savci Heijink; Marc R W Engelbrecht; Otto M van Delden; Ton G van Leeuwen; Hessel Wijkstra; Jean J M C H de la Rosette; M Pilar Laguna Pes
Journal:  BMC Cancer       Date:  2015-03-22       Impact factor: 4.430

View more
  1 in total

Review 1.  Electrochemotherapy as a New Modality in Interventional Oncology: A Review.

Authors:  Ute Probst; Irene Fuhrmann; Lukas Beyer; Philipp Wiggermann
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.